National and Kapodistrian University of Athens
ΜΟΡΦΟΠΟΙΗΣΗ ΚΑΙ IN-VITRO, IN-VIVO ΜΕΛΕΤΕΣ ΑΠΟΔΕΣΜΕΥΣΗΣ ΦΑΡΜΑΚΩΝ ΑΠΟ ΗΜΙΣΤΕΡΕΕΣ ΦΑΡΜΑΚΟΤΕΧΝΙΚΕΣ ΜΟΡΦΕΣ
Abstract
dc:descriptionSEVERAL SEMISOLID DOSAGE FORMS CONTAINING THEOPHYLLINE, OR THEOPHILLINE SODIUM GLYCINATE (TS6) OR SULINDAL WERE PREPARED TO DETERMINE THE IN-VITRO RELEASE OF THE DRUGS. THE GENERAL RANK ORDER FOR THE IN-VITRO RELEASE OF THE DRUGS WAS FOUND TO BE: GELS>MICROEMULSIONS>EMULSION GELS>EMULSION O/W>EMULSION W/O. THE SELECTED GEL CONTAINING THEOPHYLLINE 1% HAD NO EFFECT ON THE TREATMENT OF PSORIASIS. TSG WAS RELEASED FASTER IN-SITU FROM A GEL CONTAINING 2% TSG THAN FROM EMULSIONS O/W AND W/O. PENETRATION ENHANCERS SUCH AS DMSO, DMF AND UREA AT 5% AND 10%CONCENTRATION LEVELS HAD NO SIGNIFICANT EFFECT IN ENHANCING THE IN-SITU RELEASE OF TSG. THE IN-SITU RELEASE RATE OF THE DRUG WAS INCREASED AS THE CONCENTRATION LEVEL OF TSG WAS INCREASED FROM 2% TO 5% AND 10% WITHIN THE GEL BASE. THE PERCUTANEOUS ABSORPTION OF THEOPHYLLINE FROM THE SELECTED GEL (WITH 10% TSG) WAS STUDIED IN RABBITS AND IT WAS FOUND CMAX=3.28MG/ML, TMAX=10HRS, AUCO-24=49. 7MG.HR/ML. SULINDAC WAS ALSO RELEASED FASTER IN-SITU FROM A GEL CONTAINING 1% OF THE DRUG THAN FROM THE OTHER TOPICAL BASES. PENETRATION ENHANCERS SUCH AS DMSO AND DMF CAUSED A SLIGHT, NOT SIGNIFICANT DECREASE WHILE UREA AT 5% AND 10% CONCENTRATION LEVELS HAD A SIGNIFICANT INCREASE ON THE IN-SITU RELEASE RATE OF THE DRUG . THE PERCUTANEOUS ABSORPTION OF SULINDAC FROM THE SELECTED GEL (WITH 10% UREA) WAS STUDIED IN RABBITS AND IT WAS FOUND CMAX=1.76MG/ML, TMAX=5HRS, AUCO-24=22.69 MG.HR/ML.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 1988
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Dallas, Paraskevas
- Δάλλας, Παρασκευάς
Subjects
dc:subject × 22- ΑΛΟΙΦΕΣ-ΚΡΕΜΕΣ-ΓΕΛΕΣ-ΓΑΛΑΚΤΩΜΑΤΑΓΕΛΕΣ
- ΑΠΟΔΕΣΜΕΥΣΗ IN-VITRO
- Διαδερμική απορρόφηση
- Επιταχυντές Διαβατότητας
- ΗΜΙΣΤΕΡΕΕΣ ΦΑΡΜΑΚΟΤΕΧΝΙΚΕΣ ΜΟΡΦΕΣ
- Θεοφυλλίνη
- ΘΕΟΦΥΛΛΙΝΗ ΜΕΤΑ ΓΛΥΚΟΝΙΚΟΥ ΝΑΤΡΙΟΥ
- ΜΟΡΦΟΠΟΙΗΣΗ
- Σουλινδάκη
- Formulation
- IN-VITRO RELEASE
- OINTMENTS-CREAMS-GELS-EMULSION GELS
- Penetration Enhancers
- PERCUTANEOUS ABSORPTION
- SEMISOLID DOSAGE FORMS
- Sulindac
- Theophylline
- THEOPHYLLINE SODIUM GLYCINATE
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/0917